title: Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2 DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum.
authors.affiliation: From The Cardiovascular Institute, Mount Sinai Medical Center, New York, NY.
authors.forename: John A
authors.initials: JA
authors.lastname: Savino
authors.affiliation: From The Cardiovascular Institute, Mount Sinai Medical Center, New York, NY. jonathan.halperin@mssm.edu.
authors.forename: Jonathan L
authors.initials: JL
authors.lastname: Halperin
mesh_terms: D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications* / Q000208:ethnology; D002309:Cardiology; D015897:Comorbidity; D003657:Decision Making; D005060:Europe / Q000453:epidemiology; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D012737:Sex Factors; D012955:Societies, Medical; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013624:Taiwan / Q000453:epidemiology; D019851:Thrombophilia / Q000188:drug therapy* / Q000209:etiology; D014481:United States
chemical_list: D000925:Anticoagulants